Differentially expressed miRNAs are potential biomarkers for poor response to dual antiplatelet therapy in patients with coronary arterial disease (2015)
- Authors:
- USP affiliated authors: NAKAYA, HELDER TAKASHI IMOTO - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF ; HIRATA, MARIO HIROYUKI - FCF
- Unidade: FCF
- Subjects: EXPRESSÃO GÊNICA; BIOMARCADORES; DOENÇAS CARDIOVASCULARES
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2015
- Source:
- Título: Clinical Chemistry
- ISSN: 0009-9147
- Volume/Número/Paginação/Ano: v. 61, n. 10, suppl. S175, res. B-178, 2015
- Conference titles: Annual Meeting & Clinical Lab Expo (AACC)
-
ABNT
GERMANO, Juliana de Freitas et al. Differentially expressed miRNAs are potential biomarkers for poor response to dual antiplatelet therapy in patients with coronary arterial disease. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 06 maio 2026. , 2015 -
APA
Germano, J. de F., Leite, G. G. S., Maureira, A. D. C., Nakaya, H. T. I., Ferreira, F. M., Ramos, R., et al. (2015). Differentially expressed miRNAs are potential biomarkers for poor response to dual antiplatelet therapy in patients with coronary arterial disease. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Germano J de F, Leite GGS, Maureira ADC, Nakaya HTI, Ferreira FM, Ramos R, Hirata TDC, Sousa AG, Luchessi AD, Hirata RDC, Hirata MH. Differentially expressed miRNAs are potential biomarkers for poor response to dual antiplatelet therapy in patients with coronary arterial disease. Clinical Chemistry. 2015 ; 61( 10):[citado 2026 maio 06 ] -
Vancouver
Germano J de F, Leite GGS, Maureira ADC, Nakaya HTI, Ferreira FM, Ramos R, Hirata TDC, Sousa AG, Luchessi AD, Hirata RDC, Hirata MH. Differentially expressed miRNAs are potential biomarkers for poor response to dual antiplatelet therapy in patients with coronary arterial disease. Clinical Chemistry. 2015 ; 61( 10):[citado 2026 maio 06 ] - Systems biology approach to study metabolic syndrome
- Ultrassequenciamento exômico dos genes LDLR, APOB, PCSK9 e APOE em pacientes com hipercolesterolemia familiar
- miR-183-5P e miR-421 como biomarcadores epigenéticos precoces da Síndrome Metabólica
- Involvement of TLR2 and TLR4, Chlamydophila pneumoniae and mycoplasma pneumoniae in adventitial inflammation of aortic atherosclerotic aneurysm
- Interferon-'alfa' receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-a therapy of patients with chronic hepatitis C
- Atorvastatina regula negativamente la expresión de microRNAs en individuos hipercolesterolémicos
- IL-6 -174G>C gene polymorphism can be a marker of type 2 diabetes mellitus
- Effects of pioglitazone on total PPARG, PPARG2, SUR1 and KIR6.2 mRNA expression in peripheral blood leukocytes from individuals with type 2 diabetes mellitus
- Alteração da expressão dos transportadores do tipo ABC e SLC no estado hiperlipidêmico e após tratamento com atorvastatina
- Expression of ppargamma, ppargamma2, SUR1 and KIR6.2 MRNA peripheral blood leukocytes and adipose tissue in Type 2 Diabetes mellitus patients trated with pioglitazone
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
